Publication | Open Access

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematologyBiological Assignment TrialMultiple MyelomaBlood TransplantationMedicineCell TransplantationPhase 3